Introduction
A goal of gene transfer is to modulate gene expression in host cells by the introduction of genes encoding native or foreign proteins. Although viral vectors have several actual and theoretic advantages over nonviral vectors, limitations related to their immunogenicity and toxicity remain. Nonviral gene transfer has several important features, including its overall safety and lack of toxicity, but has been limited by the duration and extent of recombinant gene expression in primary target cells (1, 2) . The use of plasmid DNA to express transgenes from skeletal muscle for either systemic expression or immunization in vivo has been an important demonstration of its potential (3) . Strategies to improve the efficacy of nonviral vectors include the development of new cationic liposomes and the development of enhanced expression plasmids. Novel cationic liposomes, including GAP DLRIE/DOPE (4, 5) have increased in vivo gene expression. Enhancement of gene expression from plasmids might be obtained by developing plasmids that are capable of episomal replication (6) , by creating tissue specificity, or by altering the regulation of gene expression from the plasmid. The cytomegalovirus immediate early (CMV IE) promoter has been widely used as a potent constitutive viral promoter in expression plasmids for nonviral transfection (7, 8) . Addition of intronic sequences to expression plasmids has been shown to increase transgene expression in transient transfections in some transformed cell lines (9, 10) and in the development of transgenic animals (11, 12) . It has been suggested that the 5' untranslated portion (first exon) and first intron of the CMV IE gene may be involved in the regulation of gene expression (9, 10) from the CMV IE promoter. However, the extent and mechanism of regulation may vary with target cell and the transgene to be expressed. To increase gene expression following nonviral delivery of DNA, we investigated whether addition of untranslated sequences from the CMV IE gene would increase transgene expression in vascular smooth muscle cells (VSMCs), a target for vascular gene transfer, and to determine the sequences required for this effect.
Materials and Methods

Plasmid Development
The eukaryotic expression plasmid pCMVintCAT was obtained from Vical Inc. (San Diego, CA); it expresses the chloramphenicol acetyl transferase gene under the control of the CMV IE enhancer/ promoter (Fig. 1 ). This plasmid also contains the first exon (5' untranslated) and first intron from the CMV IE gene and a bovine growth hormone polyadenylation sequence. The plasmid pCMV-CAT contains the same backbone as pCMVint-CAT with the entire 5' untranslated and first intron sequences deleted. The plasmid pCMVint-(SacII)CAT contains 69 bp of the 5' untranslated The plasmid pRSVCAT expresses CAT under the control of the RSV promoter with the bovine growth hormone polyadenylation signal. The plasmid pRSVintCAT contains the 5 (23) . Transfections were performed in triplicate. Detection of CAT activity was performed as previously described (14) . *p = 0.002 using unpaired two-tailed Student's t-test.
(PBS) prior to addition of DNA liposomes. DNA liposomes were prepared by adding 5 ,ug of plasmid DNA to 0. (MW) band from the cells transfected with pCMVintCAT (Fig. 3) . The higher-MW (1.6 kb) form from the pCMVintCAT transfected cells was the dominant band compared to the 0.7 kb band expected for CAT seen with both transfections. Thus, the increase in transgene expression with inclusion of the 5' untranslated sequences was associated with a dominant higher-MW form of RNA than that expected for CAT mRNA.
To determine the requirements for the 5' untranslated exon and the first intron, a series of deletional mutations was created using inherent restriction sites (Fig. 4A ). Large internal deletions from within the intron failed to significantly decrease gene expression (65-10 1 %), although the larger deletions were associated with a trend toward lower gene expression. Deletion of the entire intron and the 3' portion of the first exon [pCMVint(Sac II)CAT] decreased gene expression by 56% (p = 0.01). This deletion spares the sequences from the 5' untranslated sequences previously identified as a positive regulatory domain (15) .
To determine the effects of these sequences on the duration of gene expression following transfection, transfected VSMCs were maintained without splitting for up to 20 days. The pattern of decline in gene expression over time was similar to the comparison at 1 day; internal intron deletions did not affect the extent of gene expression, while deletion of the entire intron decreased gene expression (Fig. 4B) . The degree of expression at any point appeared to be more dependent on the overall initial degree of expression rather than the rate of the decline in expression over time.
To determine the effects of adding the 5' untranslated sequences downstream of a promoter with lower basal activity, a series of similar constructs were made with the RSV promoter. Addition of the entire untranslated sequences resulted in increased expression in VSMCs by 10.3-fold ( Days the CMV IE promoter but is present with a heterologous viral promoter. The degree of increase with these sequences is greater than with the homologous promoter perhaps because the CMV promoter/enhancer is 100-fold more active than the RSV promoter in this system (data not shown).
Discussion
Gene transfer studies may provide important insights into the pathophysiology and potential treatments of human disease. A limitation of gene transfer has been the difficulty in obtaining high levels of gene expression using nonviral methods of transfer. Vascular smooth muscle cells are potential targets for the treatment of vasculoproliferative diseases, such as restenosis and atherosclerosis. Although virally mediated gene transfer has proven effective in VSMCs, there are several advantages to nonviral approaches, including the lack of toxicity and simplicity. The safety of DNA liposomes and DNA alone have now been documented in several animal toxicity and human trials (1, (15) (16) (17) (18) (19) (20) . In this report, gene expression using nonviral methods was enhanced by the addition of untranslated sequences from the CMV IE gene. Gene expression from the CMV IE promoter was increased 6-fold in target cells. This enhancement with these untranslated sequences is associated with a dominant higher-MW form of RNA than that expected for CAT. A previous study by Chapman et al. also noted this higher-molecularweight form of RNA associated with this intron, but they attributed this form to read-through of the weak SV40 polyadenylation sequence that was used in their study (9) . Our study differs from this study in that our plasmids used the bovine growth hormone polyadenylation sequence and comparisons to intronless plasmids were performed. It is the presence of this higher-MW form that differentiates between the results from the two constructs. A possible explanation for this higher-MW form of RNA might be that it is unspliced and that its presence is associated with increased protein expression in these steady-state studies.
Deletion analyses demonstrated that the enhancement was dependent upon the presence of the 5' untranslated exon and the presence of an intron. Deletion of large segments within the intron was associated with similar levels of expression compared with the parental plasmid. The greater degree of expression was seen throughout the time course of in vitro expression, but was not associated with a different time course of extinction. Expression from the weaker heterologous RSV promoter was increased 10-fold with inclusion of these nontranslated sequences. Thus, the enhancement observed with inclusion of the sequences is not limited to the homologous promoter and is dependent on inclusion of sequences within the first exon and at least a minimal intron.
Intronic sequences may increase gene expression from plasmids by either stabilizing mRNA by splicing or polyadenylation (21) or by acting as an enhancer (22) , and they have been used to enhance transgene expression in transgenic animals (11, 12) . Some (9) . This variability appeared to be due to the specific transgene expressed.
The current studies were designed to determine whether inclusion of these untranslated sequences would enhance expression in target cells for gene transfer. In these studies, the significance of the initial portion of first exon is demonstrated by a 3-fold increase in gene expression. This increase may be due to the presence of the sequence previously shown to bind LTFA and LTFB. The additional increase in expression seen with the intron does not appear to be related to the NF1 site as previously described. This site was deleted from all of the internal intron deletions without a significant decrease in gene expression. However, the presence of a minimal intron is associated with increased gene expression, suggesting either a transcriptional or post-transcriptional mechanism, such as mRNA stability as shown in previous studies. Taken together, these findings suggest that the inclusion of the first exon and intron from the CMV IE gene increases gene expression in transient transfections in VSMCs. This increase is seen in the presence of heterologous promoters and is dependent on the presence of the untranslated exon and a minimal intron. These findings might be used to develop potent gene delivery strategies that could achieve biological effects and avoid the potential toxicity of viral strategies.
